At a glance
ClinicalIndex Comparison RecordN/ACompleted· 74 enrolled
Drug / intervention
Axisother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Axis™ Allograft Dermis for Female Pelvic Floor Repair: a Prospective Post Market Study
In Brief
An observational study evaluating Axis for Pelvic Organ Prolapse. Completed, enrolled 74 participants across 5 sites.
Detailed Summary
This study is a prospective, single arm, multi-center, post-market study to evaluate the efficacy of Axis™ Allograft Dermis used for anterior, posterior or combined (anterior and posterior) pelvic organ prolapse repair.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPelvic Organ Prolapse
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2011
First PostedMar 2012
Primary CompletionNov 2018
TodayJul 2026
First PostedMar 1, 2012
Enrollment StartNov 1, 2011
Primary CompletionNov 11, 2018
TodayJul 2, 2026
Enrollment to primary: 7.0 yearsPosted 14.3 years ago
Interventions
Axisother
Coloplast's Axis™ Allograft Dermis is used for anterior, posterior or combined (anterior and posterior) pelvic organ prolapse repair.